Incyte Corporation (INCY) Director Sells 28507 Shares of Stock

Mae Love
December 7, 2017

Fisher Asset Management LLC now owns 15,532 shares of the biopharmaceutical company's stock valued at $1,956,000 after purchasing an additional 482 shares in the last quarter.

The stock decreased 0.12% or $0.11 during the last trading session, reaching $93.6. About 455,343 shares traded. It has outperformed by 1.95% the S&P500. Allsquare Wealth Ltd reported 400 shares. Torray Ltd Liability Corp holds 140,023 shares. Home Depot now has $210.21 billion valuation. The stock decreased 0.45% or $0.63 during the last trading session, reaching $137.87. About 759,055 shares traded. (NYSE:HD) has risen 18.65% since December 6, 2016 and is uptrending. It has underperformed by 12.23% the S&P500.

Among 23 analysts covering Incyte (NASDAQ:INCY), 19 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Stock traders bought 5,926 call options on the company. The rating was maintained by Brean Capital on Friday, February 12 with "Buy". The stock has "Outperform" rating by BMO Capital Markets on Thursday, October 26. The rating was upgraded by Raymond James on Thursday, September 29 to "Outperform". Tower Research Capital LLC TRC now owns 891 shares of the biopharmaceutical company's stock worth $112,000 after buying an additional 108 shares during the last quarter. The rating was maintained by Credit Suisse with "Buy" on Wednesday, November 29. The firm earned "Buy" rating on Monday, September 11 by BMO Capital Markets. Cowen reiterated a "buy" rating on shares of Incyte in a research note on Tuesday. Guardian Life Insurance Communications Of America reported 0.01% in Incyte Corporation (NASDAQ:INCY). They expect $-0.47 earnings per share, down 413.33 % or $0.62 from last year's $0.15 per share.

Investors sentiment decreased to 0.99 in 2017 Q2. During the same quarter in the previous year, the business earned $0.19 earnings per share. sell-side analysts anticipate that Incyte Corporation will post -1.33 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: "Incyte Corporation (NASDAQ:INCY) Forecasted to Post FY2020 Earnings of $4.30 Per Share" was originally posted by Week Herald and is the sole property of of Week Herald. Ladenburg Thalmann Financial Services Inc. raised its stake in shares of Incyte by 1.7% in the fourth quarter. The biopharmaceutical company reported $0.17 EPS for the quarter, topping the Zacks' consensus estimate of $0.06 by $0.11. Bb Biotech Ag owns 3.51 million shares or 13.53% of their USA portfolio.

Levin Capital Strategies LP Upped Pfizer INC (PFE) Position by $37.85 Million
Finally, UBS AG reiterated a "buy" rating and set a $38.00 price target on shares of Pfizer in a report on Monday, July 31st. The stock has a market capitalization of $212,200.00, a PE ratio of 14.42, a PEG ratio of 2.54 and a beta of 1.01.

Everton boss Allardyce to miss Europa League game at Apollon
As a result, Schneiderlin, as well as teammate Kevin Mirallas , was left out of the squad that beat Watford 3-2 at Goodison Park. The new Toffees boss will miss the match due a "pre-arranged medical appointment".

Ciena Corporation (NASDAQ:CIEN) Expected To Report Earnings On Thursday
Shares have moved $5.88 over the past month and more recently, $0.56 over the past week heading into the earnings announcement. Fortaleza Asset Management Inc. bought a new position in shares of Ciena during the 2nd quarter worth approximately $134,000.

Shares of Incyte Corporation (NASDAQ INCY) opened at $93.71 on Wednesday. Moreover, Gw Henssler And Assoc has 0.03% invested in PPL Corporation (NYSE:PPL) for 6,333 shares. Livforsakringsbolaget Skandia Omsesidigt reported 0.04% of its portfolio in Incyte Corporation (NASDAQ:INCY). Oppenheimer maintained Incyte Corporation (NASDAQ:INCY) on Tuesday, May 30 with "Hold" rating. Veritable L P has invested 0.01% in Incyte Corporation (NASDAQ:INCY). Fincl Architects Incorporated has 0% invested in Incyte Corporation (NASDAQ:INCY) for 171 shares. Moreover, Nordea Inv Mngmt has 0% invested in Incyte Corporation (NASDAQ:INCY) for 8,179 shares. Macquarie Group Inc Limited accumulated 72,573 shares. Van Eck Assocs Corporation reported 0.17% stake. Allen Invest Management Limited Liability holds 7,351 shares or 0.04% of its portfolio. The Chemical Bank holds 63,026 shares with $2.44 million value, up from 54,786 last quarter. Sector Pension Investment Board stated it has 0.02% in Incyte Corporation (NASDAQ:INCY).

Since June 12, 2017, it had 0 buys, and 1 sale for $1.95 million activity. On Monday, June 12 the insider GRYSKA DAVID W sold $1.95 million.

Investors sentiment increased to 1.17 in 2017 Q2. Its down 0.60, from 1.32 in 2017Q1. It increased, as 38 investors sold HD shares while 632 reduced holdings. Utah Retirement Systems reported 25,034 shares. Grandeur Peak Global Advsr has 1.64% invested in Genpact Limited (NYSE:G). Morgan Stanley has invested 0.04% of its portfolio in PPL Corporation (NYSE:PPL). Howard Hughes Medical Institute raised its stake in shares of Incyte by 42.2% in the first quarter. Fisher Asset Management LLC grew its position in shares of Incyte by 3.2% in the second quarter. Capital Ca reported 9,600 shares. Clearbridge Ltd Liability stated it has 0% in Quest Diagnostics Incorporated (NYSE:DGX). Peak6 Limited Partnership reported 0.03% stake. Hsbc Public Llc owns 146,011 shares or 0.01% of their USA portfolio. Boston Advisors Llc holds 0.49% or 168,460 shares in its portfolio. 475.65 million shares or 0.25% less from 476.86 million shares in 2017Q1 were reported. Westpac reported 0% of its portfolio in PPL Corporation (NYSE:PPL). The stock of Incyte Corporation (NASDAQ:INCY) earned "Buy" rating by UBS on Wednesday, November 4. The Home Depot Inc. had 92 analyst reports since August 19, 2015 according to SRatingsIntel. The company was initiated on Friday, October 16 by Cantor Fitzgerald. The rating was initiated by Barclays Capital on Thursday, August 13 with "Overweight". (NASDAQ:CBRL) has "Market Perform" rating given on Tuesday, August 30 by Telsey Advisory Group. Robert W. Baird has "Buy" rating and $34.0 target. The rating was maintained by Jefferies with "Buy" on Friday, August 4. Leerink Swann has "Outperform" rating and $94 target. (NYSE:MA) stake by 8,993 shares to 88,481 valued at $10.75 million in 2017Q2. More interesting news about Signature Bank (NASDAQ:SBNY) were released by: and their article: "Heartland Financial USA, Inc". Hanesbrands Inc (NYSE:HBI) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by

Discuss This Article